Bausch Health Companies Inc. (TSX:BHC)

Market Cap	3.21B
Revenue (ttm)	13.44B
Net Income (ttm)	133.66M
Shares Out	n/a
EPS (ttm)	0.36
PE Ratio	24.04
Forward PE	1.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	260,963
Average Volume	249,109
Open	8.95
Previous Close	8.93
Day's Range	8.64 - 8.98
52-Week Range	5.91 - 13.74
Beta	0.43
RSI	43.81
Earnings Date	Oct 29, 2025

About Bausch Health Companies

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The Intern...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Thomas Appio
• Employees: 20,700
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: BHC

Financial Performance

In 2024, Bausch Health Companies's revenue was $9.63 billion, an increase of 9.91% compared to the previous year's $8.76 billion. Losses were -$46.00 million, -92.23% less than in 2023.

Financial numbers in USD